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ABSTRACT  In the companion  paper (Sztul,  E. S., K.  E. Howell, and G.  E. Palade, J. Cell Biol., 
100:1248-1254), we have shown that pulse labeling of hepatic proteins with [35S]cysteine can 
be obtained in vivo in intact rats. Soluble label clears the plasma in ~5 min, and incorporated 
label  reaches  peak values  in the liver ~20 min after injection.  In the present study, we show 
that the  105,000-mol-wt protein (105K),  kinetically the earliest  intracellular form of secretory 
component  (SC), is the  predominant  form  found,  between  5 and  20  min  postinjection,  in 
homogeneous rough microsomal fractions. The second kinetically defined form,  i.e.,  116K, is 
the predominant species  present in relatively  homogeneous,  light Golgi fractions  in which  it 
appears at ~15 min, and peaks at ~25 min, postinjection.  The third kinetically defined form, 
120K,  is found  30 rain after injection  as the major SC species  (albeit still accompanied  by its 
immediate  precursor,  116K),  in  a sinusoidal  plasmalemmal  fraction  isolated  by  immunoad- 
sorption to anti-SC-coated Sepharose  beads. 
These findings lead to the following conclusions: (a) SC is synthesized on polysomes attached 
to the rough endoplasmic  reticulum  (ER) membrane; (b) it is partially translocated across the 
ER membrane and core glycosylated co-translationally to give a 105K peptide; (c) 105K moves 
from the  ER to the Golgi complex where it is terminally glycosylated  to give the  116K form; 
(d) the  latter moves to the sinusoidal  plasmalemma where it appears  together with the final 
mature  form,  120K.  Kinetic  evidence  indicates  that  the  vesicular  carriers  involved  in  the 
transport of SC from the Golgi complex to the sinusoidal  plasmalemma, and from the latter to 
the biliary front of the hepatocytes, are present in a Golgi heavy fraction and a crude carrier 
vesicle  fraction from which they remain to be isolated,  purified, and characterized. 
The pathway followed by the polymeric IgA receptor (i.e., the 
secretory component [SC]) ~  within hepatocytes can be delin- 
eated, and the subcellular compartments involved in its proc- 
essing can be identified, by using cell fractionation procedures 
in the framework of a pulse-chase experiment. Toward this 
end, we pulse-labeled living rats with  [35S]cysteine and  iso- 
lated, at selected, postpulse intervals, a series of cell fractions 
that represent subcellular components known to be involved 
in the synthesis and transport of proteins to the plasmalemma 
~  Abbreviations used in this paper:  ER, endoplasmic reticulum; GF, 
Golgi  fraction;  K,  x  1,000  mol  wt  (e.g.,  105K,  105,000-mol-wt 
[form]); SC, secretory component; SRA, specific radioactivity; TM, 
total microsomal fraction. 
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(reviewed in reference [26]). By analyzing these preparations, 
we have identified the major SC form present in each fraction, 
defined the kinetics of transport of each SC form into and 
out of each fraction, and in so doing, identified most of the 
compartments  in  which  SC  incurs  major  postranslational 
modifications. 
MATERIALS  AND  METHODS 
All materials  and methods used in the experiments reported in this study are 
listed or described in the companion paper (34). Procedures applied specifically 
for experiments to be reported in this paper are given below. 
General  Protocol:  Adult,  male Sprague-Dawley  rats (Charles  River 
Breeding Laboratories  Inc., Wilmington, MA) received under light ether anes- 
thesia  2  mCi [aSS]cysteine by injection into the saphenous vein.  At chosen 
1255 intervals postinjection, the livers were removed (under ether anesthesia) and 
homogenized in 0.25 M sucrose to give a 30% (wt/vol) homogenate. The latter 
was centrifuged (in a  Beckman preparative ultracentrifuge, Beckman  Instru- 
ments, Inc., Palo Alto, CA) to yield, after 10 min at 7,000 g.v, a supernate and 
a  pellet that contained cells, cell fragments,  nuclei, mitochondria, and other 
large particles. The  supernate was recovered and centrifuged for  90  min at 
105,000 g,v to give a final supernate and a pellet designated total microsomal 
fraction (TM). This fraction comprises all subcellular components involved in 
SC synthesis and transport, i.e., rough and smooth microsomes (derived from 
the endoplasmic reticulum [ER]), Golgi elements, vesicular  carriers and vesicles 
derived from the plasmalemma. The TM fraction was the starting material for 
the subsequent preparation of all cell fractions used in this study. 
To be able to compare the results obtained on cell fractions at successive 
intervals after pulse, a series of three to four experiments was carried out within 
the same week with the same batch of [3~S]cysteine.  A  second, similar series 
extended the  intervals examined, and an  overlap (at  20  min  postinjection) 
made possible the connection of the two sets of data. 
Golgi Fractions:  Two Golgi fractions, GF~÷2 and GF3,  were isolated 
from the resuspended TM  by a previously reported (16) modification of the 
procedure of Ehrenreich et al. (11).  Briefly, TM  fractions (~120 mg protein) 
resuspended  to  10  ml  in  1.22  M  sucrose  were  loaded at  the  bottom  of a 
discontinuous sucrose gradient (1.15, 0.86, 0.25 M) which was centrifuged for 
3  h  at 82,500 gay in an SW27  rotor using a  L5-65  Beckman centrifuge. The 
band that formed at the 0.25/0.86 M  interface was designated the Golgi light 
fraction (GFa+2); that found at the 0.86/1.15 M interface constituted the heavy 
Golgi fraction (GF3). 
We tested the reproducibility of our cell fractionation procedures by mea- 
suring the amount of protein and SC (quantitated by radioimmunoassay) in 
three different GF3 preparations. No significant differences were found between 
these fractions, indicating  comparable fractionation yields from one experiment 
to another. 
Rough  Microsomal Fraction:  The  residual microsomal fraction, 
which remained at the  bottom  of the centrifuge tubes after the flotation of 
GF~+2 and  GF3  components,  was  used  to  isolate rough  microsomes by  a 
modification of the procedure  of Adelman et  al. (2).  In  short,  the  residual 
microsomal fraction was adjusted to  1.4 M  sucrose with 2.0 M  stock sucrose 
solution, and 7 ml of the ensuing suspension was layered over a 2-ml cushion 
of 1.9 M sucrose. The load was overlaid with -1 ml of 0.86 M sucrose, and the 
gradient was centrifuged at 195,000 gay for ~16 h in an SW41  swinging bucket 
rotor. The rough microsomal fraction, which collected at the 1.9/1.4 M sucrose 
interface, was recovered and diluted to 0.25 M sucrose before further processing. 
Plasngalemmal Fraction:  A TM fraction was isolated as above at 30 
and 60 min postinjection of 2 mCi [3~S]cysteine.  The pellet was resuspended, 
and vesicles derived from the sinusoidal plasmalemma of the hepatocytes were 
isolated from the mixed vesicular  population of the suspension by the following 
procedure: (a) Protein A-Sepharose beads (200 ul of 60% suspension in buffer 
A  [2%  Triton  X-100,  150  mM  NaCI,  2  mM  EDTA,  30 mM  Tris-HCl, pH 
7.4]) were incubated for 60 min at 24°C with excess immune (anti-SC serum) 
or preimmune rabbit serum (50 ul per bead aliquot); (b) the coated beads were 
recovered by centrifugation and washed four times (by pelleting followed by 
resuspension) in buffer B ( 1% Triton X-100, 0.2% SDS,  150 mM NaCI, 5 mM 
EDTA,  10 mM Tris-HCl, pH 8.0) and then twice with the same buffer without 
detergents; (c) the washed beads were incubated for 2 h at room temperature 
with 500 #1  of a  TM  fraction resuspended at a  final concentration of 2  mg 
protein/ml; (d) after incubation, the beads were recovered by centrifugation 
and washed (four times, 10 min each) by gentle resuspension in 100 ul of 0.25 
M sucrose, 50 mM Tris-HCl buffer, pH 7.4; the final pellet was resuspended in 
50 mM  Tris-HCI buffer,  pH  7.4.  In some experiments, a  liver plasmalemma 
fraction (isolated as in reference 22) was used. 
Processing of Cell Fractions for SDS PACE and Fluorogra- 
phy:  Aliquots of cell fractions, containing the  same amount of proteins, 
were  solubilized in  SDS,  and  the  ensuing lysates were  processed  through 
immunoprecipitation with  anti-SC  serum  as  in  reference  34.  SDS  PAGE 
followed by fluorography of the gels or by transfer to nitrocellulose filters was 
performed as described (34). 
Electron Microscopy of Cell Fractions:  Aliquots of cell fractions 
were fixed in suspension for 60 min, at 4*C with  1.5%  glutaraldehyde (final 
concentration) in 0.1  M Na cacodylate-HCl buffer, pH 7.4.  The particles v,  ere 
pelleted at  20,000  g,, in  an  SW41  rotor  for  20  min,  and  the  pellets were 
postfixed for 2 h on ice in 1% OsO4 (final concentration) in 0.1  Na cacodylate- 
HCI, pH  7.4.  Pellet strips were processed through dehydration and embedded 
so as to allow sectioning of their entire depth (top to bottom).  The sections 
were stained by routine procedures and examined in a  Philips 301  electron 
microscope. Micrographs were taken at sufficiently  high magnification ( 11,000- 
19,000) to allow a reliable identification of the subcellular components present 
in each fraction. 
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RESULTS 
Characterization of Isolated Subcellular Fractions 
ROUGH  MICROSOME  FRACTION:  The  degree  of  ho- 
mogeneity of this fraction was assessed by electron microscopy 
(micrographs not shown). Throughout their depth, the corre- 
sponding pellets consisted of rough microsomes; morpholog- 
ically  recognizable contaminants were absent  or present  in 
negligible amounts. The fraction has been characterized bio- 
chemically and morphologically by Adelman et al. (2). Their 
results and our electron microscopic survey indicate that the 
vesicular components of the fraction are derived nearly exclu- 
sively from the rough ER. 
LIGHT GOLGI  FRACTION  (GFI+2):  The electron micro- 
scopic survey showed that this fraction consisted primarily of 
Golgi-detived  vesicles loaded with lipoprotein particles. Cis- 
ternal elements were few in number, and contaminants were 
limited to a few lysosomes and a few smooth-surfaced vesicles 
derived from unknown intracellular sources. The fraction has 
been characterized biochemically and morphologically (3, 11, 
16). Its elements are derived primarily from secretion vacuoles 
and detached rims of distended Golgi cisternae. Other Golgi 
elements (cisternae) were minor constituents. This fraction is 
not as homogeneous as the rough microsomal fraction, but it 
can be considered a  clean,  reasonably homogeneous prepa- 
ration. 
HEAVY  GOLGI  FRACTION  (GF3):  This  fraction  con- 
sisted primarily of Golgi cisternae, most of which had appar- 
ently lost their distended, lipoprotein-loaded rims during tis- 
sue  homogenization.  Golgi  vesicles  containing  lipoprotein 
particles were rare.  The fraction was, however, significantly 
contaminated by smooth-surfaced vesicles of different sizes. 
Some of them were probably derived  from the smooth ER 
and the plasmalemma; others may represent intracellular or 
transcellular vesicular carriers.  Rough microsomes were mi- 
nor contaminants of the heavy Golgi fraction. GF3 was char- 
acterized biochemically and morphologically in previous stud- 
ies  (3,  11,  16).  Our  electron  microscopy  survey  is  in  full 
agreement with findings already published. 
CRUDE  CARRIER  FRACTION:  The  vesicular elements 
found within the 1.15 M region of the sucrose density gradient 
at the end of the flotation of the Golgi fractions represent a 
heterogeneous population  in  which  small  smooth-surfaced 
vesicles and small fragments of Golgi cisternae predominate. 
Large  smooth-surfaced vesicles  of unknown derivation are 
present in smaller numbers and rough microsomes are rela- 
tively rare. 
Pulse-Chase  Conditions in Isolated Subcellular 
Fractions 
As shown in Fig. 3 of the companion paper (34), conditions 
approaching pulse-chase were obtained in  rat liver after an 
intravenous injection of [3SS]cysteine.  To document the de- 
gree to which such conditions are obtained at the intracellular 
level, we investigated the labeling kinetics of total protein in 
isolated subcellular fractions. Rough microsomes, Golgi-, and 
cartier-enriched fractions were isolated (as in Materials Meth- 
ods) from animals killed at various times after the adminis- 
tration of label and their content of radioactivity was deter- 
mined. As shown in Fig.  1, sharp peaks of label were obtained 
at 10 min postinjection in the rough microsome fraction and 
at 20 min after injection in the Golgi light fraction. Radiola- O 
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FIGURE  1  Incorporated  label  in  liver  rough  ER  and  Golgi  light 
(GFI+2) fractions.  Fractions  were  isolated  from  livers  of  animals 
sacrificed at selected times  after intravenous injection of 2 mCi [3ss]- 
cysteine.  The  graph  shows  phosphotungstic  acid-precipitable ra- 
dioactivity normalized  per gram liver (i.e., counts  per minute per 
milligram protein in fractions derived from  1 gram wet wt liver). 
beled proteins appeared in the Golgi heavy fraction (GF3) at 
5 min postinjection, increased in intensity until 15 min after 
injection, and then continuously declined  2 until the end of 
the experiment (i.e., 90 min postinjection) (Fig. 2). Compar- 
ison of the peak specific radioactivity (SRA) times in these 
three fractions indicates rapid transit ofa radiolabeled protein 
cohort through each fraction, and by inference, through the 
corresponding subcellular compartments. 
Radiolabeled proteins were detected in the mixed carrier 
fraction at 5 min postinjection, reached SRA peak at 10 min, 
and then slowly declined in intensity (not shown). The clear- 
ance of radiolabeled proteins from this  fraction was  much 
slower than from the other three, suggesting that this fraction 
contains  multiple  (temporally  separate)  compartments  in- 
volved in the transport of hepatic proteins. 
The  asymmetric  shape  of all  the  SRA  peaks,  with  the 
leading edge much sharper than the trailing edge,  indicates 
that only the entrance time of  the radiolabeled cohort and the 
time of maximum labeling can be accurately determined in 
each fraction. The egress time cannot be reliably established 
due to the extensive tail of post-peak labeling. 
Kinetics of SC Intracellular Transport at the Level 
of Cell Fractions 
Cell fractions isolated at successive intervals after adminis- 
tration of [3~S]cysteine  were solubilized and the ensuing lysates 
were used as starting preparations for the detection of  different 
forms of intracellular SC by immunoprecipitation with anti- 
SC  serum.  The  immunoprecipitates were resolved by SDS 
PAGE and their components were detected by fluorography. 
2 Peak SRA of 15 min is clearly shown in the first four lanes. The last 
six lanes were exposed for a longer time to show persistance of labeled 
proteins up to 90 min postinjection. 
Rough  Microsomal Fraction 
As shown by the fluorogram in Fig. 3,  105K--identified in 
the preceding paper (34)  as kinetically the earliest form of 
intracellular SC--was detected in this fraction as the shortest 
interval examined, i.e.,  5 min after injection. It reached half 
maximal value at ~10 min postinjection, peaked at  15 min 
postinjection, and declined first rapidly over the next 10-15 
min and then slowly enough to be still detectable at 45 min 
postinjection, albeit at a very low fraction (~5%) of its peak 
value. 
At  30  min  after injection,  116K,  kinetically the  second 
form of intracellular SC (35), became detectable in the rough 
microsomal fraction; it had initially less than one fifth of the 
intensity of the  105K band, declined slowly from this level, 
and was  still  visible  by the end of the experiment (90 min 
postinjection), at which time it was the only form of SC still 
detectable in the rough microsomal fraction. 
Taken together, these results indicate that  105K was  the 
predominant form of SC in rough microsomes, hence, in the 
rough ER of intact hepatocytes. It was the only form found 
in this fraction up to 20 min postinjection and remained the 
major form up to 30-45 min postinjection. Its relatively slow 
clearance from the rough microsomal fraction can be ascribed 
to imperfect chase conditions in intact animals, but it may 
also reflect the inherently slower transport kinetics for glyco- 
proteins (both membrane and soluble [references 21 and 33] 
and our unpublished results)  than for nonglycosylated pro- 
teins. The presence of the 116K form of SC in low concentra- 
tion in rough microsomes could be ascribed to the contami- 
nation  of this  fraction by Golgi  elements  (see  below);  an 
alternative explanation could be membrane recycling between 
the ER and the Golgi compartment in which the trimming 
and terminal glycosylation of the 105K form occur. 
Golgi Light Fraction 
The  major  SC  form  detected in  the  light (GFI+2) Oolgi 
fraction was 116K (Fig. 3). It appeared already at 15 min after 
injection,  reached  its  peak  value  between  20  and  30  min 
FIGURE  2  Radiolabeled  proteins  in  Golgi  heavy  (GF3) fractions. 
Fractions were isolated from  livers of animals sacrificed at selected 
times after intravenous  injection of 2  mCi  [3SS]cysteine. Approxi- 
mately 100/~g of protein was loaded  per well at each time point. 
A, position  of albumin, O, position  of transferrin. 
SZTUL LT AL.  Biogenesis of the Polymeric IgA Receptor. II.  1257 FIGURE 3  Appearance of biosynthetically labeled SC in subcellular fractions. Fractions were isolated from livers of rats sacrificed 
at  selected  time  intervals  after an  intravenous  administration of 2  mCi  [3SS]cysteine. Shown  are fluorographs  of SDS  PAGE 
electrophoretograms  of polypeptides immunoprecipitated with anti-SC sera; only parts of gels containing SC are included. (RER) 
SC forms detected in rough  ER fractions;  (GF,+2) SC forms detected in Golgi light (GF,÷2) fractions;  (GF3) SC forms detected in 
Golgi heavy (GF3) fractions. 
postinjection,  lost  radioactivity rapidly thereafter,  but  per- 
sisted as a  hardly detectable,  faint band  to the  end  of the 
experiment, i.e., 90 rain postinjection. A 105K band appeared 
as a minor SC form in light Golgi fractions at ~20 min after 
injection and was fully cleared by 45 min (like the same band 
in  rough  microsomes). At  peak value,  105K  amounted  to 
only a small fraction (<5%) of the radioactivity in the  116K 
band. 
The presence in  light Golgi fractions of 105K,  the  major 
SC  form found in  rough microsomes, could be ascribed to 
either contamination or membrane recycling. The first alter- 
native is not excluded, given the composition of the fraction; 
but the second alternative deserves careful consideration since 
(a) 105K was not detected in GFl+2at the times of its maximal 
labeling (10-20 min postinjection) in rough microsomal frac- 
tions;  and  (b)  its  appearance  in  GF,÷2  coincided  with  its 
clearing from rough microsomes at 20-30 rain after injection. 
Golgi Heavy Fraction 
Three SC  forms were found in this fraction (Fig.  3). The 
first,  105K,  appeared at  10 min postinjection, reached a low 
peak at  15-20 rain, and persisted at low intensity up to 30 
min  postinjection.  At  considerably lower radioactivity and 
with an apparent shift of ~5 min, it paralleled the kinetics of 
the  same  form  in  rough  microsomal  fractions.  For  these 
reasons, 105K in GF3 could be ascribed to the already known 
contamination of this fraction by rough microsomes. 
The second form,  116K,  appeared in GF3 at or before 15 
min postinjection, declined slowly in activity thereafter, and 
was no longer detectable 45  rain  after injection.  116K,  the 
predominant  Golgi  form  of SC,  appeared  in  GF3  slightly 
ahead of its detection in GF~÷2, and its gradual decline in the 
former coincided with its gradual increase in the latter.  On 
this basis, it can be assumed that GF3 contains some of the 
first Golgi subcompartments through which SC passes along 
its route from the ER, and in which it is concurrently con- 
verted from the  105K to the  116K form. 
The third  form,  120K,  kinetically the  latest intracellular 
form of SC (35), was detected in GF3 at 30 min postinjection 
and persisted while slowly declining in intensity, as the only 
form from 45 min to the end of the experiments, i.e., 90 min 
postinjection. 
The intracellular origin of the  120K form found in GF3 is 
uncertain. Since this form is found in purified plasmalemmal 
fractions (see  below),  its presence in  GF3 could be at  least 
partly explained by the latter's contamination with plasma- 
lemma-derived vesicles.  But its long persistence in GF3 up to 
and past the time (40 min) when newly synthesized SC begins 
to appear in the bile indicates that  120K must also be the SC 
form present in transcellular vesicular carriers. 
The  120K  form  of SC  was  not  detected  in  light  Golgi 
fractions (GFI+2), which, as already stated, appeared to con- 
tain only the  116K form. It was possible, however, that the 
gel in Fig.  3 did not resolve the last two forms, and that the 
broad band seen in that figure represented, in  fact, the two 
unresolved components.  To test this possibility, GFI+2 and 
GF3 isolated at 30 min postinjection were run together on the 
same gel.  The fluorograph (Fig.  4) revealed the  116K-120K 
doublet in  GF3  and  confirmed the  absence  of  120K  from 
GFl+2. 
In an immunocytochemical study, carried out by electron 
microscopy on hepatocytes in  situ, we have detected SC in 
practically all the cisternal elements of the Golgi complexes, 
but not in lipoprotein-loaded vesicles located on the trans side 
of the Golgi stacks (17).  These results suggest  that in GF~+2 
the 116K form of SC is located in Glogi cisternae rather than 
in  lipoprotein-loaded  secretory  vacuoles;  and  that  SC  and 
secretory proteins are transported from the Golgi complex to 
the sinusoidal plasmalemma by different vesicular carriers. 
Crude Carrier Vesicle Fraction 
The SC forms found in this fraction were the same as in 
GF3,  except that the  120K form appeared to be present in 
even  higher  concentration  (fluorograph  not  shown).  This 
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present in GF~ and GFI÷2  fractions. 
Fractions  were  isolated  from  the 
liver  ofananimal  killed 30 rain post- 
injection of 2 mCi [3SS]cysteine. SC 
forms  were  immunoprecipitated, 
resolved  by  SDS  PAGE, and  de- 
tected by fluorography. (Lane I) SC 
forms  present  in  GFI+2 fraction; 
(lane 2) as in lane  I  but 1/10 of the 
load; (lane  3)  SC  forms  present in 
GF3 fraction. 
preparation  may therefore contain  a  large number of plas- 
malemma-derived vesicles and/or a large fraction of the total 
population  of carrier  vesicles involved  in  the  transcellular 
transport of SC. 
Plasmalemmal Fractions 
Plasmalemmal vesicles were isolated by immunoadsorption 
on  protein  A-Sepharose  beads  coated  with  anti-SO  serum 
antibodies. The starting preparations were TM fractions pre- 
pared at either 30 min after administration of [35S]cysteine, 
i.e.,  at a  time when  newly synthesized SC was expected to 
have emerged at  the  cell  surface; or  60  min  postinjection, 
when l 16K is almost completely cleared from Golgi fractions 
and  120K  persists  as  the  major  SC  form  detected  within 
hepatocytes. As already indicated, our antiserum was raised 
against  the  biliary  form  of SC;  hence,  it  was  expected  to 
recognize only the ectodomain of the membrane forms of SC. 
The immunoadsorption procedure takes advantage of the fact 
that during liver homogenization intracellular compartments 
and the plasmalemma form vesicles that generally retain their 
right-side-out orientation.  Consequently,  the ectodomain of 
SC  is expected to  be  oriented  inwards  in  vesicles,  "micro- 
somes," derived  from the  ER,  Golgi complex, and  various 
intracellular vesicular carriers,  and  thus  inaccessible to  the 
antibodies, but directed  outwards and thereby accessible to 
antibodies in vesicles derived from the plasmalemma. More- 
over, since  vesicles derived  from the  biliary domain  of the 
hepatocyte were  shown  to  lack  SC  (22),  the  only  vesicles 
expected to bind to the insolubilized antibody should derive 
from the sinusoidal and perhaps lateral domain of the hepa- 
tocytic plasmalemma. 
As shown in  Fig.  5,  lane 1, the starting TM fraction con- 
tained, as already established (35),  all the intracellular forms 
of SC,  i.e.,  105K,  l l6K,  and  120K.  105K and  120K were 
present in nearly equal amounts slightly in excess of 116K. 
The vesicles bound to anti-SC-coated beads (Fig.  5,  lane 2) 
contained both larger SC forms, in a  120K/l 16K ratio higher 
than  in  the  starting preparation) The  105K form was not 
detectable.  The  finding  is  in  keeping with  our original  as- 
sumption that right-side-out microsomes can not bind to the 
immunobeads. When the same beads were coated with preim- 
mune serum, no binding of vesicles occurred (Fig.  5, lanes 4 
and 5). Nonradioactive plasmalemmal vesicles isolated as in 
reference 23 competed effectively with the radioactive vesicles 
of our plasmalemmal fraction in binding to the immunobeads 
(Fig.  5,  lanes 6  and  7).  A  TM  fraction  isolated at 60  min 
postinjection predominantly contained the  120K form, with 
FIGURE  5  Plasmalemmal  SC  forms.  Hepatic  TM  fractions  were 
isolated from rats killed 30 min postinjection of 2 mCi [3SS]cysteine. 
Aliquots were incubated in the absence  or presence of cold plas- 
malemma vesicles  (isolated as  in  reference 22),  with  Protein A- 
Sepharose beads coated with preimmune or anti-SC serum. In each 
case, the material bound to the immunobeads or the nonbound 
flow-through was solubilized and the lysate was used for immuno- 
precipitation  with anti-SC serum as given in Materials and Methods. 
(Lane  1') Same as Lane  1 except for shorter exposure to demon- 
strate the presence of the 116K-120K doublet; (lane  1) the starting 
TM fraction isolated 30 min postinjection; (lane 2) material bound 
to anti-SC-IgG  beads;  (lane 3) flow-through from  lane  2;  (lane  4) 
material bound  to  preimmune IgG-beads; (lane  5)  flow-through 
from lane 4;  (lane 6) anti-SC-IgG  beads were incubated with 3sS- 
labeled TM vesicles and excess cold plasmalemma  vesicles; material 
bound to immunobeads; (lane 7) flow-through from lane 6. 
lower concentrations of 116K and 105K than at 30 min. The 
elements  bound  to  the  immunosupport  contained  120K, 
traces of 116K, but no 105K. 
These results indicate clearly that both 116K and 120K are 
present  in  clean  plasmalemmal fractions,  but  they  do  not 
provide  information  about  the  site  where  the  conversion 
begins:  it could be the  carrier vesicle that brings SC to the 
sinusoidal  plasmalemma, or  it  could  be  the  plasmalemma 
itself.  Since  120K is phosphorylated (34),  it can be assumed 
that,  as  in  the  case  of other  receptors,  phosphorylation  of 
l l6K and  its ensuing conversion to  120K  occur concomi- 
tantly with  the  binding  of the  proper ligand  (lgA)2 to  the 
receptor,  but  the  assumption  remains  to  be  validated  by 
appropriate tests.  If this is the case, and if conversion begins 
rapidly upon arrival of 116K at the sinusoidal plasmalemma, 
then the  minimum time needed  for SC transport from the 
ER to the sinusoidal plasmalemma is ~30 min. 
In  the  plasmalemma,  the  l l6K  seems to  be  converted 
progressively but relatively slowly into  120K,  because  l l6K 
is present in clean plasmalemmal fractions at 60 min postin- 
jection and is greatly reduced in concentration past 45  min 
in both TM and GF3.  120K is still present in both fractions 
90 min after injection. 
To estimate the total amount of SC forms present in the 
plasmalemma (rather than the amounts of newly synthesized 
forms), we solubilized a  plasmalemmal fraction isolated by 
the procedure of Meier et al.  (22):  resolved its proteins by 
SDS PAGE, transferred the gel to nitrocellulose filters,  and 
processed the  latter through  immuneovedays with  anti-SC 
serum  followed by overlay with  12~I-labeled protein  A  and 
autoradiography. The results obtained (data not shown) in- 
dicate that the  116K and  120K bands appear to be present in 
about the same concentration in the plasmalemmal fraction, 
whereas 105K is absent. 
The soluble, biliary form of the secretory component, 80K, 
was not detected by immunoprecipitation in any of the par- 
ticulate cell fractions already mentioned. As already indicated, 
80K is easily detected in collected bile. 
3  No attempt at full recovery of SC (116K-120K) was made in this 
experiment as shown by the fluorographs  of  the flow-through  samples. 
4  This fraction contains vesicles  derived from both the sinusoidal and 
biliary domain of the hepatocytic plasmalemma. 
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In the experiments reported in this paper, we have localized 
to specific subcellular compartments the three  intracellular 
forms of SC described in the preceding paper (35).  Relevant 
cell fractions were isolated at selected intervals after a labeling 
pulse generated in living animals by an intravenous injection 
of [3SS]cysteine. The SC forms present in each fraction were 
immunoprecipitated, resolved by SDS PAGE, and detected 
by fluorography. This approach has the advantage of provid- 
ing directly applicable and physiologically relevant data on 
the biogenesis of hepatocytic SC, but it is affected, to a limited 
extent,  by the  fact that a  perfect chase of the  biosynthetic 
precursor used,  [35S]cysteine,  cannot  be achieved  in  intact 
animals. 
Direct  information  on  the  intracellular  location  of the 
biosynthetic, macromolecular precursors of membrane pro- 
teins is rarely obtained. Their location is usually inferred from 
kinetic data coupled with their sensitivity to specific endo- 
glycosidases (when  the  proteins  happen  to  have  N-linked 
oligosaccharide chains) (for examples, see references 6,  31, 
and  35).  As  a  result,  in  most  of the  pertinent  literature 
currently published, the pathway of transport for membrane 
proteins and the compartments in which they undergo specific 
postranslational  modifications are assumed on the basis of 
indirect evidence, rather than reliably identified on the basis 
of direct findings. A partial exception is represented by im- 
munocytochemical (7,  18, 31) and autoradiographic (4) stud- 
ies  which  can  help identify the  compartments involved in 
transport, but so far have not succeeded in localizing specific 
precursors. 
In the case of the hepatic SC, we have shown that the 105K 
glycopeptide, kinetically identified as the earliest biosynthetic 
form of the receptor (34), is the predominant form in homo- 
geneous rough  microsomal fractions.  In fact, it is the  only 
form detected therein at short intervals (<15 rain) postinjec- 
tion. Extrapolating from cell fractions to the situation in vivo, 
105K can be recognized as the SC precursor initially inserted 
into the rough ER membrane of hepatocytes and co-transla- 
tionally glycosylated by the addition of a still unknown num- 
ber of N-linked oligosaccharide chains. In these respects, i.e., 
SC  insertion  in  rough  ER  membranes and  co-translational 
glycosylation, our findings validate in vivo the results obtained 
by Mostov et al. (25) and Mostov and Blobel (24) in heterol- 
ogous reconstituted systems in which the mRNAs of different 
secretory components (from rabbit mammary gland and hu- 
man colonic carcinoma) were translated in vitro in the ab- 
sence or presence of microsomal membranes. 
About 15 min after injection,  105K begins to be converted 
to  I I 6K,  which  is the predominant SC  form found in  ho- 
mogeneous light Golgi fractions (GFI+2) and the only form 
detected therein at early time points. The conversion of 105K 
to l 16K apparently involves the terminal glycosylation of its 
N-linked oligosaccharide chains. 
At late time points, l 16K appeared as a minor SC form in 
rough  microsomal fractions,  and  conversely  105K was de- 
tected in light Golgi fractions as a minor component at the 
time when the peptide was cleared from rough microsomal 
fractions. The presence of these SC forms as minor compo- 
nents  in  the  two cell  fractions remains to be explained:  it 
could represent an experimental artifact due to intercontam- 
ination  between  the  fractions,  or it  may reflect membrane 
recycling at the ER-Golgi complex junction. 
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The  120K form of the receptor, kinetically the last intra- 
cellular SC form (34), was detected at 30 and 60 min postin- 
jection  in  plasmalemmal fractions  isolated  by immunoad- 
sorbtion on insolubilized anti-SC antibody. On this account, 
we  assume  that  the  fractions consist  primarily  of vesicles 
derived from the sinusoidal domain of the hepatocyte plas- 
malemma.  Since  the  fraction  contained  a  relatively  large 
amount of l l6K, in addition to  120K,  we assume that the 
conversion of the former into the latter (probably) occurs on 
the sinusoidal plasmalemma. Therefore, the  120K is either 
the mature form of the secretory component that functions 
as polymeric IgA  receptor on the  sinusoidal  aspect  of the 
plasmalemma, or, as already mentioned, is the form that has 
just bound its specific ligand. 
We have not succeeded in identifying the vesicular carriers 
that move SC from the Golgi complex to the plasmalemma. 
Our  immunocytochemical tests  (Howell,  K.  E.,  and  E.  S. 
Sztul,  manuscript submitted for publication) show that SC 
can  be detected  in  Golgi  cisternae  but  not  in  the  hepatic 
equivalent of secretion vacuoles, i.e.,  the large,  lipoprotein- 
loaded  vesicles  usually  found  on  the  trans  side  of Golgi 
cisternal stacks. 5 Vesicles of this type are a major, but not the 
only, component of the light Golgi fractions (11,  16). These 
findings suggest  that SC is present in the cisternal elements 
found  in  the  light  Golgi fractions and  is transported  from 
some compartment in the Golgi complex to the sinusoidal 
plasmalemma by other vesicular carriers than those moving 
secretory proteins to the same destination; they also suggest 
that the sorting of the two categories of proteins occurs in the 
Golgi complex at a  step or compartment that precedes the 
formation of recognizable secretion vacuoles. The existence 
of different post-Golgi pathways for membrane and secretory 
proteins has been documented in a cultured pituitary tumor 
cell  line  (At  T-20) (14).  The  hepatocyte may operate in  a 
similar way, although in its case a secretory pathway regulated 
by hormones or neurotransmitters apparently does not exist. 
Sorting at, or past, the Golgi complex has also been suggested 
for membrane proteins destined  for distinct  plasmalemma 
domains (29). 
We assume,  on the  basis of results obtained with  heavy 
Golgi fractions (GF3), that the vesicular carriers that move SC 
from the Golgi complex to the plasmalemma separate in this 
heterogeneous fraction together with vesicles of other origins 
and functions. The same heavy Golgi fraction (GF3) appar- 
ently  contains  the  vesicular carriers  that  move  120K,  the 
mature form of SC from the sinusoidal to the biliary domain 
of the hepatocyte's plasmalemma. The conclusion is based on 
the persistance of 120K in this fraction up to and past the 
time (-40 min) when newly synthesized SC begins to appear 
as a  soluble  80K protein  in  the  bile  (33).  GF3  apparently 
contains only a fraction of these transcellular carriers; the rest 
separates in  the  crude  cartier  vesicle fraction we  have de- 
scribed. We assume that the conversion of 120K, the mature 
membrane form of SC, to the soluble biliary 80K form of SC 
occurs by  proteolysis immediately upon  the  fusion  of the 
carriers with  the  biliary plasmalemma. This assumption  is 
based on: the absence of 120K SC from bile and the absence 
of the 80K form from any cell fraction. 
The transcellular vesicular carriers that move (IgA)2 bound 
5 in normal hepatocytes a certain (presumably small) fraction of these 
vacuoles are probably endosomes loaded with recovered chylomicron 
and very low density remnants (9, 15). to the membrane form of SC have been the object of a number 
of studies  that  have established  that  the transport is  rapid 
(<30 rain for the appearance of SC (IgA): complexes in bile) 
(12,  13,  19)  and  is  effected  by  smooth-surfaced  vesicular 
carriers  identified  topographically  and  kinetically  by  both 
immunocytochemistry (36) and autoradiography (5,  13,  28) 
using polymeric IgA either radioiodinated or conjugated to 
horseradish peroxidase. 
Our immunocytochemical observations (Howell, K. E., and 
E.  S.  Sztul, manuscript submitted  for publication)  indicate 
that  the initial  uptake of SC(IgA)2  complexes  may involve 
coated pits and coated vesicles,  thereby following a  pattern 
already established in a number of cases (8, 21, 37) for ligand- 
mediated  endocytosis.  This  pattern  of uptake  implies  the 
sorting of SC(IgA):  from other receptors, ligands,  and non- 
specific ingesta somewhere on the way from one (sinusoidal) 
to another (biliary) domain of the plasmalemma, as estab- 
lished for IgG transport across the intestinal epithelium in the 
newborn rat (1). 
It should be clear from the preceding discussion that the 
reliable  localization of the  intracellular precursor forms of 
membrane proteins requires homogeneous cell fractions con- 
sisting essentially of one type of vesicle. With such fractions, 
we were able to localize the 105K,  116K, and 120K forms of 
SC to the rough ER, Golgi complex, and sinusoidal plasma- 
lemma,  respectively. The identification of vesicular carriers 
of either  intracellular or transcellular type depends  on  the 
isolation of the corresponding vesicles in equally homogene- 
ous fractions by either immunoadsorption procedures (refer- 
ences 17, 23, and 30 and this paper), or by density modifying 
methods, as in the work of Courtoy et al.  (10) and Quintart 
et al. (27). The availability of vesicular carriers in reasonably 
homogeneous fractions is a  prerequisite for future attempts 
to decipher  the  mechanisms involved  in  the  regulation  of 
vesicular carrier traffic in hepatocytes as well as in all other 
eucaryotic cells. 
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